First, Ki-67 is stable and cannot be significantly affected by the immunological status of patients; whereas Ki-67 is measured using IHC in tumor tissue, hematological markers are derived from blood-based indexes that can be influenced by chronic inflammation and nutritional condition, not just by cancer. This evidence concerns the gene MKI67 and neoplasm.